KLS Keeping Law Simple Legislation in plain English

Straight-ahead summaries built from the official bill text. We keep the source links front and center and leave the decision up to you.

Back to New Hampshire

HB1335 • 2026

requiring health care providers to disclose to patients indirect financial incentives received by the provider.

requiring health care providers to disclose to patients indirect financial incentives received by the provider.

Passed Legislature

This bill passed both chambers and reached final enrollment, even if later executive action is not shown here.

Sponsor
Robert Wherry (R), Melissa Litchfield (R), Linda McGrath (R)
Last action
2026-05-08
Official status
SENATE
Effective date
Not listed

Plain English Breakdown

Using official source text because the generated explanation was unavailable or could not be confirmed against the official bill text.

requiring health care providers to disclose to patients indirect financial incentives received by the provider.

requiring health care providers to disclose to patients indirect financial incentives received by the provider.

What This Bill Does

  • requiring health care providers to disclose to patients indirect financial incentives received by the provider.

Limits and Unknowns

  • This entry is temporarily using official source text because the generated explanation could not be confirmed against the official bill text during the last sync.

Bill History

  1. 2026-05-08 S

    Inexpedient to Legislate, MA, VV === BILL KILLED ===; 05/14/2026; SJ 12

  2. 2026-05-06 S

    Committee Report: Inexpedient to Legislate; Vote 5-0; CC; 05/14/2026; SC 18

  3. 2026-04-08 S

    Hearing: 04/15/2026, Room 100, SH, 10:00 am; SC 14

  4. 2026-03-17 S

    Introduced 03/12/2026 and Referred to Health and Human Services; SJ 7

  5. 2026-03-11 H

    FLAM #2026-1120h (Rep. Nagel): AF DV 146-170 03/11/2026 HJ 7 P. 186

  6. 2026-03-11 H

    Ought to Pass : MA DV 183-147 03/11/2026 HJ 7 P. 187

  7. 2026-03-04 H

    Majority Committee Report: Ought to Pass 03/04/2026 (Vote 10-8; RC) HC 10 P. 50

  8. 2026-03-04 H

    Minority Committee Report: Refer for Interim Study

  9. 2026-02-27 H

    Executive Session: 03/04/2026 09:00 am GP 158

  10. 2026-02-11 H

    Public Hearing: 02/18/2026 02:00 pm GP 158

  11. 2025-12-01 H

    Introduced 01/07/2026 and referred to Health, Human Services and Elderly Affairs HJ 1 P. 16

Official Summary Text

requiring health care providers to disclose to patients indirect financial incentives received by the provider.

Current Bill Text

Read the full stored bill text 
HB 1335 - AS INTRODUCED

2026 SESSION
26-2929
05/06

HOUSE BILL
1335

AN ACT
requiring health care providers to disclose to patients indirect financial incentives received by the provider.

SPONSORS: Rep. Wherry, Hills. 13; Rep. Litchfield, Rock. 32; Rep. McGrath, Rock. 40

COMMITTEE: Health, Human Services and Elderly Affairs

-----------------------------------------------------------------

ANALYSIS

This bill requires a physician who receives compensation exceeding $5,000 or more as the result of a preferential promotion to disclose this information to the patient prior to prescribing any treatment associated with the source of the promotion.

- - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - -

Explanation: Matter added to current law appears in
bold italics.
Matter removed from current law appears [
in brackets and struckthrough.
]
Matter which is either (a) all new or (b) repealed and reenacted appears in regular type.
26-2929
05/06

STATE OF NEW HAMPSHIRE

In the Year of Our Lord Two Thousand Twenty-Six

AN ACT
requiring health care providers to disclose to patients indirect financial incentives received by the provider.

Be it Enacted by the Senate and House of Representatives in General Court convened:

1 New Subdivision; Physicians and Surgeons; Disclosure of Preferential Promotion Received by Provider; When Required. Amend RSA 329 by inserting after section 53 the following new subdivision:
Disclosure of Preferential Promotion
329:54 Definitions. In this subdivision:
(a) “Preferential promotion” means any financial arrangement, incentive, or compensation provided by a manufacturer, distributor, or third party that is intended to influence the recommendation, prescription, or use of a specific drug, device, treatment, or service.
(b) “Compensation” includes payments, honoraria, travel, lodging, meals, gifts, or any other transfer of value.
(c) “Reasonable costs” means expenses directly related to attendance at a medical conference, including registration fees, travel, lodging, and meals, not exceeding $5,000 in aggregate per event.
(d) “Informed consent” means the process by which a patient voluntarily confirms their willingness to undergo a particular medical intervention, after having been informed of all relevant facts, risks, benefits, and alternatives.
329:55 Disclosure Requirement.
I. Any physician who receives compensation exceeding $5,000 in aggregate within a calendar year from a single source as the result of a preferential promotion shall disclose this financial relationship to any patient prior to recommending, prescribing, or administering a product or service associated with that source.
II. The disclosure shall be made in writing and included as part of the informed consent process and shall include:
(a) The name of the entity providing the compensation.
(b) The nature and amount of compensation received.
(c) A statement that the compensation may present a potential conflict of interest.
(d) An affirmation that the recommendation is based on the practitioner’s independent clinical judgment.

2 Effective Date. This act shall take effect January 1, 2027.